CAV1 and obesity disorder: Intestinal specific-Caveolin-1 deletion (Cav1iEC−KO) mice decreased circulating free FAs and low-density lipoproteins cholesterol levels, preventing HFD-induced obesity and rapid increase in low-density lipoproteins cholesterol (Otis et al., 2017).